FDA Inspection 1129294 — Francisco G. Miranda

Francisco G. Miranda — FEI 3013525737

The FDA completed an inspection of Francisco G. Miranda on Sep 8, 2020 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 8, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Miami, FL (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.